Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acorus tatarinowii essential oil is the volatile oil extracted from the dried rhizome of Acorus tatarinowii Schott, a traditional Chinese medicinal herb. The essential oil is considered the active fraction responsible for many of the plant’s pharmacological effects. It contains a complex mixture of compounds, with β-asarone being the most abundant component. Acorus tatarinowii essential oil has demonstrated neuroprotective properties—such as protection against oxidative stress-induced cell injury in neuronal models—potentially via activation of CREB/PGC-1α signaling pathways[1]. Additionally, it exhibits cardioprotective effects against acute myocardial ischemia injury in animal models; these effects are thought to be mediated by modulation of COX-2, PPAR-α, VEGF, and cAMP signaling pathways[2]. Traditionally used for neurological and cardiovascular disorders in Chinese medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acorus tatarinowii essential oil.